Christopher Austin, GSK SVP of research technologies
GSK acquires tiny RNA startup Elsie, boosting its grand plans for developing RNA drugs
GSK is boosting its RNA ambitions, announcing Thursday it has acquired a small, privately held San Diego startup called Elsie Biotechnologies that the British drugmaker …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.